About Index Trending news
Lists
Pricing
Effector Therapeutics

Effector Therapeutics

Effector Therapeutics

Effector Therapeutics is an early-stage company focused on the discovery anddevelopment of small molecule cancer therapeutics.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series C)
$38,600,000
Employees

Team size

10+
Locations
HQ
$38,600,000 Venture capital (Series C)
Xconomy , vcaonline

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Funding Health Science
$40,000,000 Venture capital (Series B)
The San Diego Union-Tribune

Effector Therapeutics raises $40 million

Science Health Funding